Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Aug 16, 2014; 6(8): 352-358
Published online Aug 16, 2014. doi: 10.4253/wjge.v6.i8.352
Published online Aug 16, 2014. doi: 10.4253/wjge.v6.i8.352
Continued evidence for safety of endoscopic retrograde cholangiopancreatography during pregnancy
Sean Fine, Department of Internal Medicine, Warren Alpert School of Medicine Brown University, Providence, RI 02903, United States
Joshua Beirne, Department of Gastroenterology, Santa Rosa Memorial Hospital and Sutter Medical Center, Santa Rosa, CA 95404, United States
Silvia Delgi-Esposti, Fadlallah Habr, Department of Gastroenterology, Warren Alpert School of Medicine Brown University, Providence, RI 02903, United States
Author contributions: Fine S and Beirne J collected, organized, analyzed and interpreted data and drafted manuscript; Delgi-Esposti S and Habr F conceptually established the project, reviewed the data and edited the manuscript.
Correspondence to: Dr. Fadlallah Habr, MD, Department of Gastroenterology, Rhode Island Hospital, Warren Alpert School of Medicine Brown University, Physician’s Office Building, 110 Lockwood Street, Suite 116, Providence, RI 02903, United States. fhabr@lifespan.org
Telephone: +1-401-4443575 Fax: +1-401-4446316
Received: November 25, 2013
Revised: March 19, 2014
Accepted: June 27, 2014
Published online: August 16, 2014
Revised: March 19, 2014
Accepted: June 27, 2014
Published online: August 16, 2014
Core Tip
Core tip: The incidence of choledocholithiasis during pregnancy has been estimated to be 1 in 1000. Although Endoscopic retrograde cholangiopancreatography (ERCP) remains the gold standard for treatment of symptomatic choledocholithiasis during pregnancy, there still remain safety concerns about it use. Women who conceive at “extremes of age” are at an increased risk for complications during pregnancy. Our study supports the safety and efficacy of ERCP during the peripartum period for both mothers and their newborns. Neither advanced age nor trimester in which the procedure was performed carried a higher risk for adverse outcomes during pregnancy.